Maven Securities »

Immunovant shares owned by Maven Securities

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Maven Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $421k 10k 42.13

More positions owned by Maven Securities

Ishares Tr Call Call Option
Ishares Tr Put Put Option
Vaneck Etf Trust Call Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Put Put Option
Invesco Qqq Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Spdr S&p 500 Etf Tr Put Put Option
Ishares Tr Put Put Option
Select Sector Spdr Tr Put Put Option
United States Stl Corp Put Put Option
Splunk Call Call Option
United States Stl Corp Call Call Option
Capri Holdings Put Put Option

View all positions for Maven Securities

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant